PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 113 filers reported holding PTC THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $54,681,341 | +13.0% | 1,787,780 | +7.5% | 0.01% | +25.0% |
Q1 2024 | $48,385,857 | +9.0% | 1,663,068 | +3.2% | 0.00% | -20.0% |
Q4 2023 | $44,410,413 | +30.2% | 1,611,225 | +5.9% | 0.01% | +25.0% |
Q3 2023 | $34,108,579 | -42.5% | 1,521,829 | +4.3% | 0.00% | -42.9% |
Q2 2023 | $59,359,505 | -11.5% | 1,459,540 | +5.4% | 0.01% | -22.2% |
Q1 2023 | $67,109,277 | +132430.1% | 1,385,410 | +4.4% | 0.01% | +28.6% |
Q4 2022 | $50,637 | -99.9% | 1,326,624 | +3.7% | 0.01% | -30.0% |
Q3 2022 | $64,215,000 | +20.2% | 1,279,198 | -4.1% | 0.01% | +25.0% |
Q2 2022 | $53,420,000 | +10.9% | 1,333,519 | +3.3% | 0.01% | +33.3% |
Q1 2022 | $48,172,000 | -4.9% | 1,291,139 | +1.5% | 0.01% | 0.0% |
Q4 2021 | $50,668,000 | +6.5% | 1,272,130 | -0.5% | 0.01% | 0.0% |
Q3 2021 | $47,577,000 | -11.2% | 1,278,626 | +0.9% | 0.01% | -14.3% |
Q2 2021 | $53,570,000 | -1.5% | 1,267,339 | +10.3% | 0.01% | -12.5% |
Q1 2021 | $54,409,000 | -14.6% | 1,149,100 | +10.1% | 0.01% | -27.3% |
Q4 2020 | $63,724,000 | +39.1% | 1,044,148 | +6.6% | 0.01% | +22.2% |
Q3 2020 | $45,799,000 | -6.1% | 979,675 | +1.9% | 0.01% | -10.0% |
Q2 2020 | $48,772,000 | +17.9% | 961,231 | +3.6% | 0.01% | -9.1% |
Q1 2020 | $41,373,000 | -49.9% | 927,446 | -46.1% | 0.01% | +22.2% |
Q4 2019 | $82,644,000 | +210.4% | 1,720,698 | +118.6% | 0.01% | +50.0% |
Q3 2019 | $26,625,000 | -19.4% | 787,269 | +7.2% | 0.01% | -25.0% |
Q2 2019 | $33,048,000 | +28.9% | 734,417 | +7.8% | 0.01% | +14.3% |
Q1 2019 | $25,645,000 | -33.7% | 681,348 | -39.5% | 0.01% | +16.7% |
Q4 2018 | $38,672,000 | +56.5% | 1,126,812 | +114.3% | 0.01% | -14.3% |
Q3 2018 | $24,712,000 | +64.1% | 525,813 | +17.8% | 0.01% | +40.0% |
Q2 2018 | $15,060,000 | +52.4% | 446,519 | +22.2% | 0.01% | +66.7% |
Q1 2018 | $9,885,000 | +88.1% | 365,322 | +15.9% | 0.00% | +50.0% |
Q4 2017 | $5,256,000 | -27.6% | 315,112 | -13.2% | 0.00% | -33.3% |
Q3 2017 | $7,263,000 | +36.0% | 363,005 | +24.6% | 0.00% | +50.0% |
Q2 2017 | $5,340,000 | +100.8% | 291,415 | +7.8% | 0.00% | +100.0% |
Q1 2017 | $2,659,000 | -6.0% | 270,264 | +4.2% | 0.00% | 0.0% |
Q4 2016 | $2,829,000 | -11.9% | 259,306 | +13.1% | 0.00% | -50.0% |
Q3 2016 | $3,211,000 | +102.7% | 229,195 | +1.5% | 0.00% | +100.0% |
Q2 2016 | $1,584,000 | +9.8% | 225,753 | +0.8% | 0.00% | 0.0% |
Q1 2016 | $1,442,000 | -79.7% | 224,053 | +2.4% | 0.00% | -75.0% |
Q4 2015 | $7,091,000 | +24.0% | 218,886 | +2.2% | 0.00% | +33.3% |
Q3 2015 | $5,717,000 | -25.0% | 214,143 | +35.1% | 0.00% | -25.0% |
Q2 2015 | $7,627,000 | -13.6% | 158,482 | +9.2% | 0.00% | -20.0% |
Q1 2015 | $8,829,000 | +16.8% | 145,103 | -0.7% | 0.01% | +25.0% |
Q4 2014 | $7,562,000 | +32.2% | 146,088 | +12.4% | 0.00% | 0.0% |
Q3 2014 | $5,719,000 | +71.2% | 129,954 | +1.7% | 0.00% | +100.0% |
Q2 2014 | $3,341,000 | +28.0% | 127,832 | +28.0% | 0.00% | 0.0% |
Q1 2014 | $2,611,000 | +213.4% | 99,894 | +103.5% | 0.00% | +100.0% |
Q4 2013 | $833,000 | -19.8% | 49,095 | +1.4% | 0.00% | 0.0% |
Q3 2013 | $1,039,000 | – | 48,402 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Asymmetry Capital Management, L.P. | 110,794 | $3,802,000 | 10.50% |
Boxer Capital, LLC | 2,155,000 | $73,960,000 | 9.14% |
RTW INVESTMENTS, LP | 1,922,346 | $65,975,000 | 6.14% |
GREAT POINT PARTNERS LLC | 1,225,000 | $42,042,000 | 5.31% |
Opaleye Management Inc. | 190,000 | $6,520,000 | 2.43% |
SCOPIA CAPITAL MANAGEMENT LP | 1,626,965 | $55,837,000 | 1.89% |
SPHERA FUNDS MANAGEMENT LTD. | 345,500 | $11,858,000 | 1.34% |
SECTORAL ASSET MANAGEMENT INC | 233,536 | $8,015,000 | 1.09% |
Elk Creek Partners, LLC | 377,674 | $12,962,000 | 1.08% |
Orbimed Advisors | 1,519,700 | $52,156,000 | 0.96% |